Get More Information on Sanger Sequencing Market - Request Sample Report
The Sanger Sequencing Market Size was valued at USD 2,901.15 Million in 2023, and is expected to reach USD 12,356.57 Million by 2032, and grow at a CAGR of 18.63% Over the Forecast Period of 2024-2032.
The Sanger sequencing market has experienced significant growth in recent years, thanks to big advances in genome sequencing, biotechnology, and a strong showing of support from the federal government. The recent statistics from the U.S. National Institutes of Health (NIH) for 2023 show that, globally, governments have allocated more than USD 40 billion to genomic research, and this has increased the need for devices like Sanger sequencers. In the same vein, the European Commission has allocated another 2.7 billion euros for its Horizon Europe initiative, which means that genomics will be integrated into precision medicine. This will deepen the market for Sanger sequencers in hospitals and research institutions.
Programs run by governments such as the UAS's "All of Us" research program and the 100,000 Genomes Project in the UK have used the technology of gene sequencing as well Sanger Sequencing in its case to an ever-increasing extent within their countries' health systems, expanding its application so that it now encompasses clinical diagnostics and personalized medicine. This kind of backing from national sources, together with the ascent of pharmaceutical and biotechnological companies, means that the market for Sanger sequencing will go on growing strongly. In 2023 the situation was that as genetic diseases became more prevalent, more precise diagnostics were demanded, and ever-rising numbers of people engaged in sequence-based research brought broad market support from these sectors.
Key Drivers:
Increasing Demand for Genetic Testing and Personalized Medicine is Driving the Adoption of Sanger Sequencing in Clinical Diagnostics.
Advancements in Biotechnology and Sequencing Automation are Making Sanger Sequencing More Efficient and Accessible for Research and Development.
Restraints:
The High Cost of Sanger Sequencing Compared to Next-Generation Sequencing (NGS) Limits Its Widespread Use in Large-Scale Genomic Projects.
Limited Throughput and Slower Processing Times Reduce Its Applicability in High-Throughput Sequencing Applications.
Opportunity:
The Growing Focus on Precision Medicine and The Rise of Pharmacogenomics Present Opportunities for Sanger Sequencing in Drug Discovery and Personalized Treatments.
Emerging Markets, particularly in Asia-Pacific and Latin America, Offer Untapped Potential for Sanger Sequencing Adoption in Research and Clinical Settings.
KEY MARKET SEGMENTATION:
By Type
In 2023, the largest market segment within the Sanger sequencing market by type was Reagents and Consumables, holding a significant 40.00% share. This dominance can be attributed to the recurring nature of reagent usage in the sequencing workflow. As Sanger sequencing requires frequent replacement of reagents such as DNA polymerases, primers, and nucleotides for every run, this segment generates consistent demand. According to the U.S. Food and Drug Administration (FDA), the use of consumables in genetic sequencing has grown in parallel with increased genetic testing across clinical and research laboratories. The FDA noted that 55% of all laboratory genetic tests conducted in 2023 involved sequencing protocols, with Sanger sequencing being a primary method for targeted sequencing.
Government-funded research projects and public-private partnerships in genomic research have significantly contributed to this growth. For instance, NIH grants supported USD 11 billion worth of research into gene-related studies in 2023, with a large portion of these funds allocated for the purchase of reagents and consumables. Additionally, with the increase in diagnostic testing post-pandemic, particularly in identifying mutations linked to inherited diseases, demand for these consumables is forecasted to remain high. Their high utilization across diagnostics and research ensures the reagent segment will continue its dominant position in the market.
Need any customization research on Sanger Sequencing Market - Enquiry Now
By Technology
When analyzing the Sanger sequencing market by technology, Capillary Electrophoresis emerged as the leading technology in 2023, supported by its precise and efficient sequencing capabilities. According to government data from the National Human Genome Research Institute (NHGRI), capillary electrophoresis-based sequencing accounted for 45% of all genetic sequencing performed globally in 2023. This technology's ability to deliver high accuracy in base pair identification makes it an essential tool in both clinical and research applications. The FDA and European Medicines Agency (EMA) have consistently recognized capillary electrophoresis as the gold standard for sequence validation in diagnostic labs.
Microfluidic technologies and automated sequencing systems, while growing, have not surpassed capillary electrophoresis due to cost and scalability issues. Capillary electrophoresis remains the most accessible and widely adopted technology, supported by government-funded clinical studies and research that focus on its continued integration into healthcare systems. With its lower error rate and established regulatory approval, capillary electrophoresis will likely maintain its leadership in the Sanger sequencing technology segment for the foreseeable future.
By Application
Clinical Diagnostics was the dominant application segment in the Sanger sequencing market in 2023, contributing to approximately 38% of the total market share. This is primarily due to the increasing adoption of Sanger sequencing for identifying and confirming genetic mutations, particularly in cases of inherited diseases. In a 2023 report by the Centers for Disease Control and Prevention (CDC), genetic testing volume increased by 30%, with Sanger sequencing forming a crucial part of diagnostics for cystic fibrosis, muscular dystrophy, and various forms of cancer.
Government funding through health institutions such as Medicare and Medicaid in the U.S. has also contributed to the uptake of Sanger sequencing in diagnostics. In 2023, the U.S. government allocated USD 6 billion for genetic testing under its national healthcare programs, highlighting a substantial portion dedicated to sequencing for disease screening. Furthermore, government-backed precision medicine initiatives like the Cancer Moonshot initiative have accelerated the deployment of Sanger sequencing in hospitals and clinical settings. The method's accuracy and reliability in detecting small genetic variations make it indispensable in clinical diagnostics, ensuring its continued dominance in this market segment.
In 2023, North America was the leading region in the global Sanger sequencing market, accounting for a substantial 48% market share. This dominance is primarily driven by the high concentration of research institutions, advanced healthcare infrastructure, and significant government investment in genomics. According to data from the NIH, the U.S. government alone allocated USD 22.8 billion toward genomics research in 2023, a large portion of which supported sequencing technologies, including Sanger sequencing. Additionally, the U.S. government’s Precision Medicine Initiative has further boosted demand for sequencing technologies by integrating them into mainstream healthcare practices.
Canada has also contributed to North America's leadership, with the Canadian Institutes of Health Research (CIHR) investing heavily in genomic projects, particularly those focused on population health. In 2023, CIHR funding for genetic research reached CAD 3.2 billion. The region’s favorable regulatory environment, where agencies like the FDA provide expedited approvals for sequencing technologies, has also stimulated market growth. Furthermore, North America's strong pharmaceutical and biotech sectors heavily rely on Sanger sequencing for drug development and genetic research, further bolstering the region's dominance.
The players operating in the Sanger sequencing market are the following:
Thermo Fisher Scientific: Applied Biosystems 3130xl Genetic Analyzer
Eurofins Scientific: Eurofins Genomics Sanger Sequencing
LGC Group: LGC Sanger Sequencing
Macrogen: Macrogen Sanger Sequencing
Beckman Coulter: CEQ 8000 Genetic Analysis System
Illumina: MiSeq Sanger Sequencing
Qiagen: GeneRead Sanger Sequencing Kits
BGI Group: BGI Sanger Sequencing Service
Agilent Technologies: 2100 Bioanalyzer
PerkinElmer: Applied Biosystems 3500 Genetic Analyzer
SequeGen: SequeGen Sanger Sequencing
GenScript: GenScript Sanger Sequencing
Creative Biolabs: Creative Biolabs Sanger Sequencing
Genewiz: Genewiz Sanger Sequencing
Nebula Genomics: Nebula Sanger Sequencing
GeneDx: GeneDx Sanger Sequencing
Invitae: Invitae Sanger Sequencing
Myriad Genetics: Myriad Genetics Sanger Sequencing
Sanger Institute: Sanger Institute Sanger Sequencing
University of Washington: University of Washington Sanger Sequencing & Other Players
RECENT DEVELOPMENTS
In May 2023, Source Genomics, a division of Source BioScience (a biotech company), opened a new laboratory located in the North of England offering Sanger sequencing services designed for quicker turnaround times to maximize data readiness.
The Tamil Nadu Forest Department in India started a DNA sequencing facility (sanger-based sequencing) under the Centre for Wildlife Forensics and a wildlife histopathology laboratory under the Centre for Animal Care Sciences in February 2023.
| Report Attributes | Details |
|---|---|
|
Market Size in 2023 |
US$ 2,901.15 Million |
|
Market Size by 2032 |
US$ 12,356.57 Million |
|
CAGR |
CAGR of 18.63% From 2024 to 2032 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2032 |
|
Historical Data |
2020-2022 |
|
Report Scope & Coverage |
Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
|
Key Segments |
•By Type (Reagents and Consumables, Instruments, Software, Services) |
|
Regional Analysis/Coverage |
North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
|
Company Profiles |
Thermo Fisher, Eurofins Scientific, LGC Group, Macrogen, Beckman Coulter, Illumina, Qiagen, BGI Group, Applied Biosystems, PerkinElmer & other players |
|
Key Drivers |
•Increasing Demand for Genetic Testing and Personalized Medicine is Driving the Adoption of Sanger Sequencing in Clinical Diagnostics. |
|
RESTRAINTS |
•The High Cost of Sanger Sequencing Compared to Next-Generation Sequencing (NGS) Limits Its Widespread Use in Large-Scale Genomic Projects. |
Ans: The North America led the Sanger Sequencing Market.
Ans: The Sanger Sequencing Market will be valued at USD 12,356.57 Million in 2032.
Ans: Reagents and Consumables held the largest share in the Sanger Sequencing Market in 2023.
Ans: The expected CAGR of the Global Sanger Sequencing Market during the forecast period is 18.63%.
Ans: The Sanger Sequencing Market was valued at USD 2,901.15 Million in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Sanger Sequencing Market Segmentation, by Type
7.1 Chapter Overview
7.2 Reagents and Consumables
7.2.1 Reagents and Consumables Market Trends Analysis (2020-2032)
7.2.2 Reagents and Consumables Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Instruments
7.3.1 Instruments Market Trends Analysis (2020-2032)
7.3.2 Instruments Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Software
7.4.1 Software Market Trends Analysis (2020-2032)
7.4.2 Software Market Size Estimates and Forecasts to 2032 (USD Million)
7.5 Services
7.5.1 Services Market Trends Analysis (2020-2032)
7.5.2 Services Market Size Estimates and Forecasts to 2032 (USD Million)
8. Sanger Sequencing Market Segmentation, by Technology
8.1 Chapter Overview
8.2 Capillary Electrophoresis
8.2.1 Capillary Electrophoresis Market Trends Analysis (2020-2032)
8.2.2 Capillary Electrophoresis Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Microfluidics
8.3.1 Microfluidics Market Trends Analysis (2020-2032)
8.3.2 Microfluidics Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Automated Sequencing Systems
8.4.1 Automated Sequencing Systems Market Trends Analysis (2020-2032)
8.4.2 Automated Sequencing Systems Market Size Estimates and Forecasts to 2032 (USD Million)
9. Sanger Sequencing Market Segmentation, by Application
9.1 Chapter Overview
9.2 Clinical Diagnostics
9.2.1 Clinical Diagnostics Market Trends Analysis (2020-2032)
9.2.2 Clinical Diagnostics Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Research and Development
9.3.1 Research and Development Market Trends Analysis (2020-2032)
9.3.2 Research and Development Market Size Estimates and Forecasts to 2032 (USD Million)
9.4 Pharmaceuticals
9.4.1 Pharmaceuticals Market Trends Analysis (2020-2032)
9.4.2 Pharmaceuticals Market Size Estimates and Forecasts to 2032 (USD Million)
9.5 Forensics
9.5.1 Forensics Market Trends Analysis (2020-2032)
9.5.2 Forensics Market Size Estimates and Forecasts to 2032 (USD Million)
10. Sanger Sequencing Market Segmentation, by End User
10.1 Chapter Overview
10.2 Academic and Research Institutes
10.2.1 Academic and Research Institutes Market Trends Analysis (2020-2032)
10.2.2 Academic and Research Institutes Market Size Estimates and Forecasts to 2032 (USD Million)
10.3 Clinical Laboratories
10.3.1 Clinical Laboratories Market Trends Analysis (2020-2032)
10.3.2 Clinical Laboratories Market Size Estimates and Forecasts to 2032 (USD Million)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Pharmaceutical and Biotechnology Companies Market Trends Analysis (2020-2032)
10.4.2 Pharmaceutical and Biotechnology Companies Market Size Estimates and Forecasts to 2032 (USD Million)
10.5 Government and Forensic Labs
10.5.1 Government and Forensic Labs Market Trends Analysis (2020-2032)
10.5.2 Government and Forensic Labs Market Size Estimates and Forecasts to 2032 (USD Million)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trends Analysis
11.2.2 North America Sanger Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.2.3 North America Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.2.4 North America Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.2.5 North America Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.2.6 North America Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.2.7 USA
11.2.7.1 USA Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.2.7.2 USA Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.2.7.3 USA Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.2.7.4 USA Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.2.8 Canada
11.2.8.1 Canada Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.2.8.2 Canada Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.2.8.3 Canada Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.2.8.4 Canada Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.2.9 Mexico
11.2.9.1 Mexico Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.2.9.2 Mexico Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.2.9.3 Mexico Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.2.9.4 Mexico Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Trends Analysis
11.3.1.2 Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.3.1.3 Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.4 Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.1.5 Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.6 Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.1.7 Poland
11.3.1.7.1 Poland Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.7.2 Poland Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.1.7.3 Poland Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.7.4 Poland Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.1.8 Romania
11.3.1.8.1 Romania Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.8.2 Romania Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.1.8.3 Romania Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.8.4 Romania Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.1.9 Hungary
11.3.1.9.1 Hungary Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.9.2 Hungary Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.1.9.3 Hungary Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.9.4 Hungary Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.1.10 Turkey
11.3.1.10.1 Turkey Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.10.2 Turkey Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.1.10.3 Turkey Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.10.4 Turkey Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.1.11 Rest of Eastern Europe
11.3.1.11.1 Rest of Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.1.11.2 Rest of Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.1.11.3 Rest of Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.1.11.4 Rest of Eastern Europe Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2 Western Europe
11.3.2.1 Trends Analysis
11.3.2.2 Western Europe Sanger Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.3.2.3 Western Europe Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.4 Western Europe Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.5 Western Europe Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.6 Western Europe Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.7 Germany
11.3.2.7.1 Germany Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.7.2 Germany Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.7.3 Germany Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.7.4 Germany Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.8 France
11.3.2.8.1 France Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.8.2 France Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.8.3 France Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.8.4 France Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.9 UK
11.3.2.9.1 UK Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.9.2 UK Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.9.3 UK Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.9.4 UK Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.10 Italy
11.3.2.10.1 Italy Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.10.2 Italy Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.10.3 Italy Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.10.4 Italy Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.11 Spain
11.3.2.11.1 Spain Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.11.2 Spain Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.11.3 Spain Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.11.4 Spain Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.12 Netherlands
11.3.2.12.1 Netherlands Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.12.2 Netherlands Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.12.3 Netherlands Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.12.4 Netherlands Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.13 Switzerland
11.3.2.13.1 Switzerland Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.13.2 Switzerland Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.13.3 Switzerland Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.13.4 Switzerland Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.14 Austria
11.3.2.14.1 Austria Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.14.2 Austria Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.14.3 Austria Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.14.4 Austria Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.3.2.15 Rest of Western Europe
11.3.2.15.1 Rest of Western Europe Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.3.2.15.2 Rest of Western Europe Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.3.2.15.3 Rest of Western Europe Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.3.2.15.4 Rest of Western Europe Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4 Asia Pacific
11.4.1 Trends Analysis
11.4.2 Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.4.3 Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.4 Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.5 Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.6 Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4.7 China
11.4.7.1 China Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.7.2 China Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.7.3 China Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.7.4 China Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4.8 India
11.4.8.1 India Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.8.2 India Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.8.3 India Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.8.4 India Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4.9 Japan
11.4.9.1 Japan Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.9.2 Japan Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.9.3 Japan Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.9.4 Japan Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4.10 South Korea
11.4.10.1 South Korea Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.10.2 South Korea Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.10.3 South Korea Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.10.4 South Korea Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4.11 Vietnam
11.4.11.1 Vietnam Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.11.2 Vietnam Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.11.3 Vietnam Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.11.4 Vietnam Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4.12 Singapore
11.4.12.1 Singapore Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.12.2 Singapore Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.12.3 Singapore Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.12.4 Singapore Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4.13 Australia
11.4.13.1 Australia Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.13.2 Australia Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.13.3 Australia Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.13.4 Australia Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.4.14 Rest of Asia Pacific
11.4.14.1 Rest of Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.4.14.2 Rest of Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.4.14.3 Rest of Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.4.14.4 Rest of Asia Pacific Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5 Middle East and Africa
11.5.1 Middle East
11.5.1.1 Trends Analysis
11.5.1.2 Middle East Sanger Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.5.1.3 Middle East Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.4 Middle East Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.1.5 Middle East Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.6 Middle East Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.1.7 UAE
11.5.1.7.1 UAE Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.7.2 UAE Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.1.7.3 UAE Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.7.4 UAE Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.1.8 Egypt
11.5.1.8.1 Egypt Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.8.2 Egypt Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.1.8.3 Egypt Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.8.4 Egypt Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.1.9 Saudi Arabia
11.5.1.9.1 Saudi Arabia Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.9.2 Saudi Arabia Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.1.9.3 Saudi Arabia Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.9.4 Saudi Arabia Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.1.10 Qatar
11.5.1.10.1 Qatar Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.10.2 Qatar Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.1.10.3 Qatar Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.10.4 Qatar Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.1.11 Rest of Middle East
11.5.1.11.1 Rest of Middle East Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.1.11.2 Rest of Middle East Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.1.11.3 Rest of Middle East Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.1.11.4 Rest of Middle East Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.2 Africa
11.5.2.1 Trends Analysis
11.5.2.2 Africa Sanger Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.5.2.3 Africa Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.2.4 Africa Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.2.5 Africa Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.2.6 Africa Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.2.7 South Africa
11.5.2.7.1 South Africa Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.2.7.2 South Africa Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.2.7.3 South Africa Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.2.7.4 South Africa Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.2.8 Nigeria
11.5.2.8.1 Nigeria Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.2.8.2 Nigeria Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.2.8.3 Nigeria Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.2.8.4 Nigeria Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.5.2.9 Rest of Africa
11.5.2.9.1 Rest of Africa Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.5.2.9.2 Rest of Africa Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.5.2.9.3 Rest of Africa Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.5.2.9.4 Rest of Africa Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.6 Latin America
11.6.1 Trends Analysis
11.6.2 Latin America Sanger Sequencing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
11.6.3 Latin America Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.4 Latin America Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.6.5 Latin America Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.6 Latin America Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.6.7 Brazil
11.6.7.1 Brazil Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.7.2 Brazil Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.6.7.3 Brazil Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.7.4 Brazil Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.6.8 Argentina
11.6.8.1 Argentina Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.8.2 Argentina Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.6.8.3 Argentina Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.8.4 Argentina Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.6.9 Colombia
11.6.9.1 Colombia Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.9.2 Colombia Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.6.9.3 Colombia Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.9.4 Colombia Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America Sanger Sequencing Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
11.6.10.2 Rest of Latin America Sanger Sequencing Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)
11.6.10.3 Rest of Latin America Sanger Sequencing Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
11.6.10.4 Rest of Latin America Sanger Sequencing Market Estimates and Forecasts, by End User (2020-2032) (USD Million)
12. Company Profiles
12.1 Thermo Fisher Scientific
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Eurofins Scientific
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 LGC Group
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Macrogen
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Beckman Coulter
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Illumina
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Qiagen
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 PerkinElmer
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 BGI Group
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Applied Biosystems
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
Reagents and Consumables
Instruments
Software
Services
By Technology
Capillary Electrophoresis
Microfluidics
Automated Sequencing Systems
By Application
Clinical Diagnostics
Research and Development
Pharmaceuticals
Forensics
By End-User
Academic and Research Institutes
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Government and Forensic Labs
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Oncology Drugs Market size was USD 221.38 Billion in 2023 and is expected to Reach USD 525.08 Billion by 2031 and grow at a CAGR of 11.4% over the forecast period of 2024-2031.
The Shadow less Surgical Lights Market Size was valued at USD 1.71 Bn in 2023 and will reach to USD 2.46 Bn by 2032 and grow at a CAGR of 4.11% by 2024-2032.
The Digital Clinical Trials Market was valued at USD 8.70 Bn in 2023 and is expected to reach at $13.86 Bn in 2031 and grow at a CAGR of 6 % by 2024-2031.
The Autoimmune Disease Therapeutics Market size was valued at USD 72.05 billion in 2022 and it is expected to be worth around USD 94.87 billion by 2030 growing at a remarkable CAGR of 3.5% over the forecast period 2023-2030.
The Liver Cancer Therapeutics Market was valued at USD 3.62 billion in 2023 and is expected to reach USD 19.13 billion by 2032 at a compound annual growth rate of 20.3% during the forecast period from 2024 to 2032.
The Peripheral Neuropathy Market valued USD 1.48 billion in 2023, estimated to surpass USD 2.38 billion by 2032 with a compound annual growth rate of 5.46% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
